Search Results - "Annals of hematology"

Refine Results
  1. 1

    Mechanism of thrombocytopenia in COVID-19 patients by Xu, Panyang, Zhou, Qi, Xu, Jiancheng

    Published in Annals of hematology (01-06-2020)
    “…Since December 2019, a novel coronavirus has spread throughout China and across the world, causing a continuous increase in confirmed cases within a short…”
    Get full text
    Journal Article
  2. 2

    Blood type and outcomes in patients with COVID-19 by Latz, Christopher A., DeCarlo, Charles, Boitano, Laura, Png, C. Y. Maximilian, Patell, Rushad, Conrad, Mark F., Eagleton, Matthew, Dua, Anahita

    Published in Annals of hematology (01-09-2020)
    “…This study aimed to determine if there is an association between ABO blood type and severity of COVID-19 defined by intubation or death as well as ascertain if…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Hematological findings in coronavirus disease 2019: indications of progression of disease by Liu, Xiaoqing, Zhang, Run, He, Guangsheng

    Published in Annals of hematology (01-07-2020)
    “…Coronavirus disease 2019 (COVID-19) is a new human infectious disease. The etiology for this outbreak is a novel coronavirus named severe acute respiratory…”
    Get full text
    Journal Article
  5. 5

    Copper deficiency anemia: review article by Myint, Zin W., Oo, Thein H., Thein, Kyaw Z., Tun, Aung M., Saeed, Hayder

    Published in Annals of hematology (01-09-2018)
    “…Copper is a crucial micronutrient needed by animals and humans for proper organ function and metabolic processes such as hemoglobin synthesis, as a…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure by Marchetti, Monia

    Published in Annals of hematology (01-08-2020)
    “…COVID-19 pandemia is a major health emergency causing hundreds of deaths worldwide. The high reported morbidity has been related to hypoxia and inflammation…”
    Get full text
    Journal Article
  12. 12

    Clozapine-induced agranulocytosis by Mijovic, Aleksandar, MacCabe, James H.

    Published in Annals of hematology (01-11-2020)
    “…Wider use of clozapine, one of the most effective antipshychotic drugs, is precluded by its propensity to cause agranulocytosis. Currently, clozapine is used…”
    Get full text
    Journal Article
  13. 13

    Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States by Medeiros, Bruno C., Satram-Hoang, Sacha, Hurst, Deborah, Hoang, Khang Q., Momin, Faiyaz, Reyes, Carolina

    Published in Annals of hematology (01-07-2015)
    “…Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older. We examined patient characteristics, treatment patterns, and survival…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Hematologic disorders associated with COVID-19: a review by Rahi, Mandeep Singh, Jindal, Vishal, Reyes, Sandra-Patrucco, Gunasekaran, Kulothungan, Gupta, Ruby, Jaiyesimi, Ishmael

    Published in Annals of hematology (01-02-2021)
    “…Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2. Primarily an infection of the lower respiratory tract, it is now well…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy by Jiang, Huiwen, Liu, Lin, Guo, Tao, Wu, Yaohui, Ai, Lisha, Deng, Jun, Dong, Jian, Mei, Heng, Hu, Yu

    Published in Annals of hematology (01-07-2019)
    “…The CD19-targeted chimeric antigen receptor T cell (CAR-T) therapy has been widely proved effective on relapsed and refractory (r/r) B cell acute lymphoblastic…”
    Get full text
    Journal Article
  20. 20

    Management of myelofibrosis after ruxolitinib failure by Harrison, Claire N, Schaap, Nicolaas, Mesa, Ruben A

    Published in Annals of hematology (01-06-2020)
    “…Myelofibrosis is a BCR-ABL1–negative myeloproliferative neoplasm characterized by anemia, progressive splenomegaly, extramedullary hematopoiesis, bone marrow…”
    Get full text
    Journal Article